Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
5,351,717
-
Share change
-
-7,377
-
Total reported value
-
$30,556,000
-
Price per share
-
$5.71
-
Number of holders
-
29
-
Value change
-
-$41,824
-
Number of buys
-
12
-
Number of sells
-
6
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2018
As of 30 Sep 2018,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,351,717 shares.
The largest 10 holders included
ARIEL INVESTMENTS, LLC, Stonepine Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Vanguard Group Inc, NEW YORK STATE COMMON RETIREMENT FUND, BRIDGEWAY CAPITAL MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, and BARD ASSOCIATES INC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.